Publikationen in Zusammenarbeit mit Forschern von Hospital Clinico Universitario de Valencia (15)

2021

  1. Health Outcomes and Primary Adherence to Secondary Prevention Treatment after St-Elevation Myocardial Infarction: a Spanish Cohort Study

    Journal of Cardiovascular Translational Research, Vol. 14, Núm. 2, pp. 308-316

2020

  1. Secondary adherence to beta-blockers after ST-elevation myocardial infarction without ventricular dysfunction

    Medicina Clinica, Vol. 155, Núm. 6, pp. 242-248

2018

  1. Applicability of the STOPP/START criteria to older polypathological patients in a long-term care hospital

    European Journal of Hospital Pharmacy , Vol. 25, Núm. 6, pp. 310-316

  2. Investigation of different iontophoretic currents profiles for short-term applications in cosmetics

    Pharmaceutics, Vol. 10, Núm. 4

2017

  1. Impact of Undernutrition on the Pharmacokinetics and Pharmacodynamics of Anticancer Drugs: A Literature Review

    Nutrition and Cancer, Vol. 69, Núm. 4, pp. 555-563

  2. Levofloxacin effect on erlotinib absorption. Evaluation of the interaction in undernutrition situations through population pharmacokinetic analysis in rats

    Biopharmaceutics and Drug Disposition, Vol. 38, Núm. 5, pp. 315-325

  3. Population pharmacokinetics of lenalidomide in multiple myeloma patients

    Cancer Chemotherapy and Pharmacology, Vol. 79, Núm. 1, pp. 189-200

  4. Tenofovir-induced toxicity in renal proximal tubular epithelial cells: Involvement of mitochondria

    AIDS, Vol. 31, Núm. 12, pp. 1679-1684

2016

  1. A Wide Linearity Range Method for the Determination of Lenalidomide in Plasma by High-Performance Liquid Chromatography: Application to Pharmacokinetic Studies

    Journal of Laboratory Automation, Vol. 21, Núm. 6, pp. 806-810

  2. A model-based meta-analysis of sofosbuvir-based treatments in chronic hepatitis C patients

    International Journal of Antimicrobial Agents, Vol. 47, Núm. 3, pp. 184-194

2015

  1. Impact of nutritional status on the pharmacokinetics of erlotinib in rats

    Biopharmaceutics and Drug Disposition, Vol. 36, Núm. 6, pp. 373-384

2007

  1. Stability studies of binary mixtures of haloperidol and/or midazolam with other drugs for parenteral administration

    Journal of Palliative Medicine, Vol. 10, Núm. 6, pp. 1306-1311

2004

  1. Hipertensión y valores de NT-proBNP. Su importacia en el diagnóstico de insuficiencia cardíaca

    Revista Espanola de Cardiologia, Vol. 57, Núm. 5, pp. 396-402

2003

  1. Quantification of proinflammatory cytokines in the urine of congestive heart failure patients. Its relationship with plasma levels

    European Journal of Heart Failure, Vol. 5, Núm. 1, pp. 27-31

1997

  1. Significatión clínica de la infección por Blastocystis hominis: Estudio epidemiológico

    Medicina Clinica, Vol. 108, Núm. 16, pp. 608-612